Jesús María
Prieto Valtueña
Researcher to 2014
Publications by the researcher in collaboration with Jesús María Prieto Valtueña (28)
2020
-
Brain ventricular enlargement in human and murine acute intermittent porphyria
Human molecular genetics, Vol. 29, Núm. 19, pp. 3211-3223
-
Identifying differentially expressed micrornas, target genes, and key pathways deregulated in patients with liver diseases
International Journal of Molecular Sciences, Vol. 21, Núm. 19, pp. 1-16
2019
-
The cirrhotic liver is depleted of docosahexaenoic acid (DHA), a key modulator of NF-κB and TGFβ pathways in hepatic stellate cells
Cell Death and Disease, Vol. 10, Núm. 1
2018
-
TMEM173 Alternative Spliced Isoforms Modulate Viral Replication through the STING Pathway
ImmunoHorizons, Vol. 2, Núm. 11, pp. 363-376
2017
-
Phase 1–2 pilot clinical trial in patients with decompensated liver cirrhosis treated with bone marrow–derived endothelial progenitor cells
Translational Research, Vol. 188, pp. 80-91.e2
-
X-box Binding Protein 1 Regulates Unfolded Protein, Acute-Phase, and DNA Damage Responses During Regeneration of Mouse Liver
Gastroenterology, Vol. 152, Núm. 5, pp. 1203-1216.e15
2016
-
Factors related to increased resting energy expenditure in men with liver cirrhosis
European Journal of Gastroenterology and Hepatology, Vol. 28, Núm. 2, pp. 139-145
-
Insulin-like growth factor I (IGF-I) expressed from an AAV1 vector leads to a complete reversion of liver cirrhosis in rats
PLoS ONE, Vol. 11, Núm. 9
-
Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria
Journal of Hepatology, Vol. 65, Núm. 4, pp. 776-783
2015
-
Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection
Molecular Therapy - Methods and Clinical Development, Vol. 2, pp. 15006
2014
-
Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation
Journal of Hepatology, Vol. 60, Núm. 5, pp. 1017-1025
-
Comparación de las sondas M y XL para estimar la rigidez hepática por medio de elastografía de transición
Gastroenterologia y Hepatologia, Vol. 37, Núm. 4, pp. 233-239
2013
-
Increased liver stiffness values in patients with heart failure
Acta Gastro-Enterologica Belgica, Vol. 76, Núm. 2, pp. 246-250
-
Prognostic factors and prevention of radioembolization-induced liver disease
Hepatology, Vol. 57, Núm. 3, pp. 1078-1087
-
Safety and liver transduction efficacy of raav5-cohpbgd in nonhuman primates: A potential therapy for acute intermittent porphyria
Human Gene Therapy, Vol. 24, Núm. 12, pp. 1007-1017
2012
-
AAV vectors transduce hepatocytes in vivo as efficiently in cirrhotic as in healthy rat livers
Gene Therapy, Vol. 19, Núm. 4, pp. 411-417
2011
-
Prognosis of hepatocellular carcinoma in relation to treatment across BCLC stages
Annals of Surgical Oncology, Vol. 18, Núm. 7, pp. 1964-1971
-
Transarterial therapies for hepatocellular carcinoma
Expert Opinion on Pharmacotherapy, Vol. 12, Núm. 7, pp. 1057-1073
2010
-
Analysis of prognostic factors after yttrium-90 radioembolization of advanced hepatocellular carcinoma
International Journal of Radiation Oncology Biology Physics, Vol. 77, Núm. 5, pp. 1441-1448
-
Insulin-like growth factor i gene transfer to cirrhotic liver induces fibrolysis and reduces fibrogenesis leading to cirrhosis reversion in rats
Hepatology, Vol. 51, Núm. 3, pp. 912-921